There were 465 press releases posted in the last 24 hours and 430,740 in the last 365 days.

Xtalks Announces Its May 2016 Webinars


/EINPresswire.com/ -- TORONTO, ON--(Marketwired - May 02, 2016) - Upcoming free, educational webinars from Xtalks Life Sciences will feature topics on FDA Compliance, Clinical Trials, Drug Development, Drug Discovery, Health Economics and Outcomes and Food Safety.

Stay on top of current hot topics through free webinars presented by leading experts in pharma, biotech and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field! Visit www.xtalks.com to check out our upcoming webinars. Or click below to learn more about each webinar:

FDA COMPLIANCE

CLINICAL TRIALS

DRUG DEVELOPMENT

DRUG DISCOVERY

HEALTH ECONOMICS AND OUTCOMES

FOOD SAFETY

ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com.

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx.

Contact:
Dian Razak 
Tel: +1 (416) 977-6555 ext 284 
Email: drazak@xtalks.com


Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.